- $1.40bn
- $1.37bn
- $201.61m
Enfusion Inc expected to post earnings of 3 cents a share - Earnings Preview
Brief: Enfusion Inc Board Appoints Michael Spellacy
Brief: Enfusion Inc - On December 22, Board Appointed Oleg Movchan, Co's Interim CEO, To Position Of CEO Of Company, Effective Immediately
Brief: Enfusion Announces Resignation Of Chief Financial Officer
Brief: Enfusion Inc Files For Mixed Shelf Of Up To $150 Million - SEC Filing
Enfusion gains on Q3 profit beat, PT raise
U.S. RESEARCH ROUNDUP-Expensify, NVIDIA, Signature Bank
Enfusion Inc reports results for the quarter ended in September - Earnings Summary
Brief: Enfusion Inc Reports Quarterly Total Revenue Grew To $39.2 Million, Up 35% Year-Over-Year
Enfusion Inc expected to post earnings of 2cents a share - Earnings Preview
NYSE ORDER IMBALANCE 84076.0 SHARES ON BUY SIDE
Brief: Enfusion Appoints Oleg Movchan Interim Chief Executive Officer
NYSE ORDER IMBALANCE 375988.0 SHARES ON SELL SIDE
Enfusion Inc reports results for the quarter ended in June - Earnings Summary
Brief: Enfusion Inc - QTRLY Loss Per Share Was $0.03
Enfusion Inc expected to post earnings of 2 cents a share - Earnings Preview
NYSE ORDER IMBALANCE 78618.0 SHARES ON BUY SIDE
U.S. RESEARCH ROUNDUP-Humacyte, Hyatt Hotels, Poseida Therapeutics
Enfusion Inc reports results for the quarter ended in March - Earnings Summary